RIBOT, Emeline Julie; BOUZIER-SORE, Anne-Karine; BOUCHAUD, Véronique; MIRAUX, Sylvain; DELVILLE, Marie-Hélène; FRANCONI, Jean-Michel; VOISIN, Pierre

doi:10.1038/sj.cgt.7701060

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

RIBOT, Emeline Julie
Centre de résonance magnétique des systèmes biologiques [CRMSB]

BOUZIER-SORE, Anne-Karine
Centre de résonance magnétique des systèmes biologiques [CRMSB]

BOUCHAUD, Véronique
Centre de résonance magnétique des systèmes biologiques [CRMSB]

Langue

Article de revue

Ce document a été publié dans

Cancer Gene Therapy. 2007, vol. 14, n° 8, p. 724-737

Nature Publishing Group

Résumé en anglais

Microglia are phagocytic cells that are chemoattracted by brain tumors and can represent up to 70% of the tumor cell population. To get insight into gene therapy against glioma, we decided to take advantage of those microglia properties and to use those cells as vehicles to transport simultaneously a suicide gene (under the control of a heat-sensitive promoter) and contrast agents to localize them by magnetic resonance imaging before applying any therapeutic treatment. Thymidine kinase (TK) expression and its functionality after gancyclovir administration were investigated. After the heat shock (44°C and 20 min), TK was expressed in 50% of the cells. However, after gancyclovir treatment, 90% of the cells died by apoptosis, showing an important bystander effect. Then, the cells were incubated with new lanthanide contrast agents to check both their potential toxicity and their MR properties. Results indicate that the nanoparticles did not induce any cell toxicity and yield a hypersignal on MR images at 4.7 T. These in vitro experiments indicate that microglia are good candidates as vectors in gene therapy against brain tumors. Finally, microglia containing gadolinium-grafted nanoparticles were injected in the close vicinity of C6 tumor, in a mouse. The hyperintensive signal obtained on in vivo images as well as its retention time show the potential of the novel contrast agents for cellular imaging.< Réduire

Mots clés en anglais

Microglia

HSP70 promoter

TK/GCV system

Rhodamine-grafted nanoparticles

T1-contrast agent

MRI

Métadonnées

Licence d’utilisation du document

Microglia used as vehicles for both inducible thymidine kinase gene therapy and MRI contrast agents for glioma therapy

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

DOI

Origine

Unités de recherche